CEO of Chicago-based Translation Services Company to Present at International Program in Miami

Angelo Passalacqua, CEO, will be a featured speaker at the 6th Annual Clinical Trials Innovation ProgrammeChicago-based BURG Translations, an international company specializing in technical translation services, recently announced that Angelo Passalacqua, CEO, will be a featured speaker at the 6th Annual Clinical Trials Innovation Programme in Miami at the Sheraton Miami Hotel & Executive Meeting Center on July 28 and 29. The event will feature 25 innovative thought leaders from around the world as key note speakers. Through strategic keynote addresses, themed tracks and dedicated networking sessions, attendees will have the chance to be educated about the latest industry trends, improve their company’s brand awareness, debut new products and solutions, and meet with new and existing clients.

“We are proud to contribute to this important event,” said Passalacqua, whose company specializes in translations for clinical trials. “BURG Translations has a solid foundation in partnering with pharmaceutical companies, clinical research organizations, institutional research boards and hospitals, and we look forward to sharing our insights with these key decision makers,” he added. “We are also looking forward to learning from our peers at esteemed companies such a Pfizer, AstraZeneca and Bristol Myers-Squibb.”

Passalacqua will speak about how to successfully partner with a specialist translations company. He is a certified John Maxwell Coach, ISO 9001:2008 Lead Auditor, Associate at the Higher Education Academy and holds a PhD in biostatistics from King’s College London and BSc in management from Purdue University. Passalacqua speaks English and Spanish fluently and maintains basic fluency in Mandarin. In his free time, he volunteers with Global Brigades, a charity he co-founded in London, as an executive board member.

Before joining BURG Translations, Passalacqua served as a management consultant for the healthcare industry, helping pharmaceutical companies price and valuate potential medication. He has also taught at King’s College London and the North China Institute of Science & Technology.

About BURG Translations
Since 1936, Chicago-based BURG Translations has been dedicated to providing superior technical translation services across multiple global industries. The company offers a wide variety of language services to Fortune 500 clients ranging from prestigious medical journals, legal firms and leaders in biotech and manufacturing to new tech startups, universities, healthcare groups and life science organizations. The key to BURG’s success lies in its more than 75 years of cultivating an elite corps of translation professionals. More information can be found at www.burgtranslations.com or by calling (312) 263-3379.

###

FOR MORE INFORMATION:
Melissa Garcia
press@burgtranslations.com
219.628.5175

FOR IMMEDIATE RELEASE

Editor’s note: to receive a high resolution image, please email press@burgtranslations.com.

What Facebook teaches us about globalization and translation

What Facebook teaches us about globalization and translationLove it or hate it, Facebook continues to keep the world wrapped around its finger. If you need proof of its world dominance, take a look Facebook’s most recent annual report.

Here are just a few of the surprising statistics and claims made in the report:

  • Generated $13 billion in the EMEA region;

  • Had a $21 billion economic impact on Central and South America;

  • Had a $100 billion economic impact on the United States

Read more

Spain and Italy continue to lose in patent translation service fight

Spain and Italy continue to lose in patent translation service fightAs a business, you know how expensive it is to file a patent. From the cost of filing to the expense of having the necessary patent translation service, patent filings are costly to companies.

With that in mind, it’s easy to understand why businesses continue their frustration over Spain and Italy’s non-stop battle against the European Patent Office (EPO).

For almost a half-century, Spain and Italy have fought the EPO to require that patents be filed in Spanish or Italian. Right now, the claims for a patent section must be filed in the EU in the top three dominant languages: English, German, and French. Spain and Italy want to add Spanish and Italian to that list of languages. Read more